| 000 | 00936 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250517194610.0 | ||
| 264 | 0 | _c20190711 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1527-7755 | ||
| 024 | 7 |
_a10.1200/JCO.2017.76.5347 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLo, Serigne N | |
| 245 | 0 | 0 |
_aReply to M. Horiguchi et al. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _c03 2018 |
||
| 300 |
_a722-723 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIpilimumab |
| 650 | 0 | 4 | _aMelanoma |
| 650 | 0 | 4 | _aNivolumab |
| 700 | 1 | _aSandhu, Shahneen | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 36 _gno. 7 _gp. 722-723 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2017.76.5347 _zAvailable from publisher's website |
| 999 |
_c27983495 _d27983495 |
||